Netflix To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Netflix To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Netflix 的涨幅将超过 15%？以下是周三分析师的十大预测
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
华尔街顶级分析师改变了对这些知名人士的看法。要全面了解所有分析师评级变动，包括上调和降级，请参阅我们的分析师评级页面。
- Barclays cut the price target for Prologis, Inc. (NYSE:PLD) from $153 to $141. Barclays analyst Anthony Powell maintained an Overweight rating. Prologis shares fell 1.6% to close at $125.14 on Tuesday. See how other analysts view this stock.
- Truist Securities slashed the price target for Berry Global Group, Inc. (NYSE:BERY) from $75 to $68. Truist Securities analyst Michael Roxland downgraded the stock from Buy to Hold. Berry Global shares fell 0.4% to close at $59.23 on Tuesday. See how other analysts view this stock.
- Wedbush increased Netflix, Inc. (NASDAQ:NFLX) price target from $615 to $725. Wedbush analyst Michael Pachter maintained an Outperform rating. Netflix shares rose 0.3% to close at $629.24 on Tuesday. See how other analysts view this stock.
- Keefe, Bruyette & Woods boosted the price target for Wells Fargo & Company (NYSE:WFC) from $56 to $62. Keefe, Bruyette & Woods analyst David Konrad downgraded the stock from Outperform to Market Perform. Wells Fargo shares fell 0.1% to close at $56.68 on Tuesday. See how other analysts view this stock.
- JP Morgan raised KB Home (NYSE:KBH) price target from $68.5 to $70.5. JP Morgan analyst Michael Rehaut maintained a Neutral rating. KB Home shares fell 0.3% to close at $68.18 on Tuesday. See how other analysts view this stock.
- Keybanc boosted the price target for Intuit Inc. (NASDAQ:INTU) from $700 to $720. Keybanc analyst Alex Markgraff maintained an Overweight rating. Intuit shares gained 0.2% to close at $640.05 on Tuesday. See how other analysts view this stock.
- Tigress Financial increased Target Corporation (NYSE:TGT) price target from $180 to $210. Tigress Financial analyst Ivan Feinseth maintained a Buy rating. Target shares slipped 0.01% to close at $172.64 on Tuesday. See how other analysts view this stock.
- HC Wainwright & Co. boosted Delcath Systems, Inc. (NASDAQ:DCTH) price target from $18 to $20. HC Wainwright & Co. analyst Swayampakula Ramakanth maintained a Buy rating. Delcath Systems shares fell 1.1% to close at $4.61 on Tuesday. See how other analysts view this stock.
- Jefferies raised Nuvation Bio Inc. (NYSE:NUVB) price target from $1.4 to $10. Jefferies analyst Michael Yee upgraded the stock from Hold to Buy. Nuvation Bio shares rose 28% to close at $2.88 on Tuesday. See how other analysts view this stock.
- Canaccord Genuity cut Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) price target from $21 to $9. Canaccord Genuity analyst Edward Nash maintained a Buy rating. Rani Therapeutics shares fell 1.7% to close at $3.18 on Tuesday. See how other analysts view this stock.
- 巴克莱将普洛斯公司（纽约证券交易所代码：PLD）的目标股价从153美元下调至141美元。巴克莱分析师安东尼·鲍威尔维持增持评级。周二，普洛斯股价下跌1.6％，收于125.14美元。看看其他分析师如何看待这只股票。
- Truist Securities将贝瑞环球集团有限公司（纽约证券交易所代码：BERY）的目标股价从75美元下调至68美元。Truist Securities分析师迈克尔·罗克斯兰将该股的评级从买入下调至持有。周二，贝瑞环球股价下跌0.4％，收于59.23美元。看看其他分析师如何看待这只股票。
- Wedbush将Netflix公司（纳斯达克股票代码：NFLX）的目标股价从615美元上调至725美元。Wedbush分析师迈克尔·帕切特维持跑赢大盘的评级。周二，Netflix股价上涨0.3％，收于629.24美元。看看其他分析师如何看待这只股票。
- Keefe、Bruyette & Woods将富国银行（纽约证券交易所代码：WFC）的目标股价从56美元上调至62美元。Keefe、Bruyette & Woods分析师戴维·康拉德将该股的评级从跑赢大盘下调至市场表现。富国银行股价周二下跌0.1％，收于56.68美元。看看其他分析师如何看待这只股票。
- 摩根大通将KB Home（纽约证券交易所代码：KBH）的目标股价从68.5美元上调至70.5美元。摩根大通分析师迈克尔·雷豪特维持中性评级。周二，KB Home股价下跌0.3％，收于68.18美元。看看其他分析师如何看待这只股票。
- Keybanc将Intuit Inc.（纳斯达克股票代码：INTU）的目标股价从700美元上调至720美元。Keybanc分析师亚历克斯·马克格拉夫维持增持评级。周二，Intuit股价上涨0.2％，收于640.05美元。看看其他分析师如何看待这只股票。
- Tigress Financial将塔吉特公司（纽约证券交易所代码：TGT）的目标股价从180美元上调至210美元。Tigress Financial分析师伊万·费恩塞斯维持买入评级。周二，目标股价下跌0.01％，收于172.64美元。看看其他分析师如何看待这只股票。
- HC Wainwright & Co. 将德尔卡斯系统公司（纳斯达克股票代码：DCTH）的目标股价从18美元上调至20美元。HC Wainwright & Co. 分析师Swayampakula Ramakanth维持买入评级。周二，德尔卡斯系统股价下跌1.1％，收于4.61美元。看看其他分析师如何看待这只股票。
- 杰富瑞将Nuvation Bio Inc.（纽约证券交易所代码：NUVB）的目标股价从1.4美元上调至10美元。杰富瑞分析师迈克尔·伊将该股从 “持有” 上调至 “买入”。周二，Nuvation Bio股价上涨28％，收于2.88美元。看看其他分析师如何看待这只股票。
- Canaccord Genuity将Rani Therapeutics Holdings, Inc.（纳斯达克股票代码：RANI）的目标股价从21美元下调至9美元。Canaccord Genuity分析师爱德华·纳什维持买入评级。周二，Rani Therapeutics股价下跌1.7％，收于3.18美元。看看其他分析师如何看待这只股票。